Certified by Founder Lodge
BioCentriq
![BioCentriq](/images/flags/US.png)
START UP
1 Disclosed Funding Rounds $29,200,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BioCentriq is an established, highly collaborative, global cell therapy CDMO. The company has been successfully manufacturing drug products for use in human clinical trials since 2022. In Jun
Date | Round | Raised | Participating Investors |
---|---|---|---|
January, 04 ,2024 | Series A | $29,200,000 |